Breast cancer can be classified into five intrinsic molecular subtypes with prognostic and therapeutic implications using the PAM50 gene signature: luminal A (LumA), luminal B (LumB), HER2-enriched (HER2), basal-like (BL), and normal-breast-like (NBL)24–27. This evidence concerns the gene ERBB2 and breast cancer.